PEB
PACIFIC ED FPO NZX [PEB]
Healthcare · ASX Small Cap
$0.1700 -5.6%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +6First seen: 2026-02-25
Score Breakdown
Technical44
Catalyst43
Sentiment50
Fundamental36
Momentum62
Risk Gate37
Active Signals
Bullish Signals
- RSI approaching oversold
- Sharp 5-day decline (-17.1%)
- Above 200-day MA (long-term uptrend)
- Low cash runway (3 quarters) - dilution risk
- Moderate P/S ratio (10.1x)
- Revenue in sharp decline (-40%)
- CANSLIM I: Institutional ownership (34%)
- Strong 12-1 momentum (+100%)
- Days to cover very high (11.1)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD momentum weakening
- Piotroski F-Score weak (3/9)
- Deeply negative margins (-189%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-40%)
Recent Catalysts
NONE Panel Expresses Support for Urine-Based Biomarkers
NONE Change in substantial holding
NONE Medicare Contractor Novitas Schedules Expert Panel
NEGATIVE Trading Halt
Announcement tone +3pts
Recent ASX Announcements
| 2026-02-22 | Panel Expresses Support for Urine-Based Biomarkers PRICE SENSITIVE |
| 2026-02-19 | Trading Halt PRICE SENSITIVE |
| 2026-02-13 | Change in substantial holding |
| 2026-02-08 | Medicare Contractor Novitas Schedules Expert Panel |
| 2026-01-30 | Change in substantial holding |
Key Metrics
$184.0M
Market Cap
96K
Avg Volume
1.9x
Vol Ratio
$0.07 — $0.22
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-102.3%
ROE
-189.4%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 86% |
| L | Leader vs Laggard | pass | RS: 6 |
| I | Institutional Sponsorship | pass | Inst: 34% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #101 of 119 · Sector avg: 51
View all Healthcare signals →